Sartorius and Immunochina Partner to Advance Immunotherapy Development
December 03, 2018 02:00 AM Pacific Standard Time BEIJING–(BUSINESS WIRE)–Sartorius Stedim Biotech (SSB), a leading international supplier of the biopharmaceutical industry, through its China affiliate, and Beijing-based Immunochina Pharmaceuticals, announced today that both parties have entered into a collaboration. Under the terms of the relationship, Immunochina will gain preferred access to SSB’s bioprocess technology platform... Read more